Acumen Pharmaceuticals In...

NASDAQ: ABOS · Real-Time Price · USD
1.42
0.02 (1.43%)
At close: Aug 15, 2025, 3:59 PM
1.45
2.11%
After-hours: Aug 15, 2025, 07:52 PM EDT

Acumen Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-102.33M -52.37M -42.86M -100.61M
Depreciation & Amortization
178K 184K 169K 4K
Stock-Based Compensation
9.63M 6.14M 3.06M 922K
Other Working Capital
7.38M 4.13M 3.43M -259K
Other Non-Cash Items
-5.35M -888K 487K 81.42M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
11.65M 3.87M 3.99M 298K
Operating Cash Flow
-86.22M -43.06M -35.15M -17.96M
Capital Expenditures
-16K -21K -161K -40K
Cash Acquisitions
n/a 3K -39.35K n/a
Purchase of Investments
-170.73M -250.63M -41.51M -104.08M
Sales Maturities Of Investments
218.77M 78.98M 80.86M n/a
Other Investing Acitivies
n/a n/a 39.35K n/a
Investing Cash Flow
48.03M -171.67M 39.19M -104.12M
Debt Repayment
-739K 30M n/a n/a
Common Stock Repurchased
-41K n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-230K -151K 115K 1.88M
Financial Cash Flow
6.93M 151.75M 3.91M 200.47M
Net Cash Flow
-31.26M -62.98M 7.94M 78.39M
Free Cash Flow
-86.23M -43.09M -35.31M -18M